Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction

Area of Science:

• Cardiology
• Cardiovascular Imaging
• Metabolic Syndrome

Background:

• Cardiovascular risk factors are typically linked to coronary atherosclerosis.
• This study investigates their association with left ventricular (LV) dysfunction, including dilatation, impaired contractility, and reduced myocardial blood flow (MBF) in patients without ischemic heart disease.

Purpose of the Study:

• To determine if cardiovascular risk factors are associated with LV dilatation, contractile impairment, and reduced MBF in patients with non-ischemic LV dysfunction.
• To identify specific risk factors contributing to the severity of LV impairment and reduced MBF.

Main Methods:

• Studied 81 patients with mild-to-severe non-ischemic LV dysfunction (ejection fraction 37% ± 12%).
• Assessed absolute myocardial blood flow (MBF) using positron emission tomography with (13)N-ammonia at rest and during hyperemia (dipyridamole).
• Employed multivariate logistic regression to analyze associations between risk factors and LV dysfunction/MBF.

Main Results:

• Overt LV dysfunction was present in 52% of patients; severely depressed hyperemic MBF in 51%.
• Low high-density lipoprotein cholesterol (HDL-C) and newly diagnosed non-insulin-dependent diabetes/insulin resistance (NIDD/IR) were independently associated with overt LV dysfunction.
• Low HDL-C and NIDD/IR were also independently associated with severely depressed hyperemic MBF.

Conclusions:

• Low HDL-C and NIDD/IR are significant predictors of more severe LV impairment.
• These metabolic factors are associated with reduced hyperemic MBF in patients with non-ischemic LV dysfunction.
• Highlights the importance of managing dyslipidemia and diabetes in this patient population.